Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spider scared? imagining worst case may help you face your fears

NCT ID NCT05424250

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding occasional aversive imagery (imagining your worst fear about spiders) during exposure therapy helps reduce spider phobia more than standard exposure alone. 67 spider-fearful adults completed a one-session training with seven steps, from looking at a spider to touching it. One week later, researchers measured fear levels and avoidance behavior to see which group improved more.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exposure therapy with occasional aversive imagery
What this could lead to
If it works, this could point toward a more effective way to treat phobias using exposure therapy.
What could go wrong
This is a small, early-stage study with only 67 participants. The results may not apply to everyone with spider fear, and the benefit of adding aversive imagery is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

67 people

The number who actually took part.

Started

Jun 2022

Finished

Sep 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Elevated score on Spider Phobia Questionnaire (SPQ) \> 17 Exclusion Criteria: * Severe allergies to bees/spiders/insects * current psychotherapeutic/psychiatric treatment * past psychotherapeutic/psychiatric treatment due to anxiety problems * current or past psychotic symptoms * current suicidal intent * experience with exposure-based treatment * current psychopharmacological medication * severe cardiovascular, respiratory or neurological diseases

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arachnophobia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

animal phobia Arachnophobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Philipps-University Marburg

    Marburg, Hesse, 35037, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.